Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis IV: Nursing Management

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial.

JAMA·2025

Same author

Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit.

Thrombosis and haemostasis·2024

Same author

Lightening the load for paediatric ITP: The importance of health-related quality of life.

British journal of haematology·2024

Same author

The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia.

Blood advances·2024

Same author

Immune Thrombocytopenia (ITP): Current Limitations in Patient Management.

Medicina (Kaunas, Lithuania)·2020

Same author

Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice.

Blood advances·2019

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Evaluating bleeding severity in immune thrombocytopenia (ITP).

Cindy E Neunert¹

¹Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA, cindy.neunert@utsouthwestern.edu.

Annals of Hematology

|March 24, 2010

Summary

Pediatric immune thrombocytopenia (ITP) research needs better patient-focused outcomes. Current trials often use platelet counts, but validated bleeding assessments are crucial for guiding effective ITP treatment.

More Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Related Experiment Videos

Last Updated: Jun 14, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Area of Science:

Pediatric Hematology
Clinical Trial Design
Patient-Reported Outcomes

Background:

Immune thrombocytopenia (ITP) is common in children, yet prospective research and treatment guidelines are limited.
Severe bleeding is rare in pediatric ITP, making it infeasible as a primary clinical trial outcome.
Current trials often rely on platelet count as a surrogate for bleeding risk, neglecting patient experience.

Purpose of the Study:

To highlight the limitations of using platelet count as the sole outcome in pediatric ITP clinical trials.
To emphasize the need for valid and reliable patient-related outcome measures, specifically for bleeding severity.
To advocate for rigorous methodological approaches in developing and analyzing patient-reported outcome tools for ITP.

Main Methods:

Review of existing literature on pediatric ITP clinical trials and outcome measures.
Analysis of the feasibility of using severe bleeding events as a primary endpoint.
Discussion of the requirements for developing robust patient-related outcome measurement tools.

Main Results:

Prospective studies in pediatric ITP are scarce, leading to variable treatment approaches.
Severe bleeding events are too rare to serve as a feasible primary outcome in clinical trials.
Existing bleeding assessment instruments lack demonstrated validity and reliability.

Conclusions:

Platelet count alone is insufficient for assessing treatment efficacy and patient well-being in pediatric ITP.
Development of validated bleeding assessment tools is essential for improving pediatric ITP research.
Rigorous methods are needed to create and analyze patient-reported outcome measures to guide ITP treatment decisions.